<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>26343154</identifier>
<setSpec>1578-8989</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Ribera Santasusana, Josep María</dc:author>
<dc:author>Fernandez Sojo, Jesús</dc:author>
<dc:author>Morgades, Mireia</dc:author>
<dc:author>Batlle Massana, Montserrat</dc:author>
<dc:author>Vives Polo, Susana</dc:author>
<dc:author>Quesada, María Dolores</dc:author>
<dc:description xml:lang="en">BACKGROUND Bacterial infection remains a frequent complication in patients receiving a hematopoietic stem cell transplantation (HSCT). However, the impact of the antibacterial prophylaxis mortality in these patients is controversial. PATIENTS AND METHODS Retrospective comparison of 2 consecutive groups of patients undergoing HSCT receiving (n=132) or not (n=107) antibacterial prophylaxis with levofloxacin. RESULTS 41% of patients receiving prophylaxis with levofloxacin had microbiologically documented infection (MDI) with bacteremia, compared with 40% of those not receiving levofloxacin. The frequency of gram-negative bacteremia was 11 and 38%, the resistance to levofloxacin was 39 and 14%, and the mortality was 8 and 7%, respectively. CONCLUSIONS In our experience, the use of levofloxacin as prophylaxis in HSCT was associated with a lower frequency of gram-negative bacteremia but was not associated with a decreased rate of MDI and did not influence their outcome. In contrast, there was an increase in quinolone resistance in patients treated with levofloxacin.</dc:description>
<dc:type>Comparative Study</dc:type>
<dc:language>es</dc:language>
<dc:subject>Hematopoietic stem cell transplant</dc:subject>
<dc:subject>Resistance</dc:subject>
<dc:subject>Levofloxacin</dc:subject>
<dc:subject>Bacteriemia</dc:subject>
<dc:subject>Levofloxacino</dc:subject>
<dc:subject>Prophylaxis</dc:subject>
<dc:subject>Trasplante de progenitores hematopoyéticos</dc:subject>
<dc:subject>Profilaxis</dc:subject>
<dc:subject>Resistencia</dc:subject>
<dc:subject>Bacteremia</dc:subject>
<dc:date>2016 Jan 01 </dc:date>
<dc:title xml:lang="es">Estudio comparativo sobre la utilidad de la profilaxis antibacteriana con levofloxacino en pacientes receptores de un trasplante de progenitores hematopoyéticos.</dc:title>
<dc:title xml:lang="en">[Comparative study on the usefulness of antibacterial prophylaxis with levofloxacin in patients submitted to hematopoietic stem cell transplantation].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
